Virtu KCG Holdings LLC lifted its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST) by 67.3% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,518 shares of the medical instruments supplier’s stock after acquiring an additional 3,025 shares during the period. Virtu KCG Holdings LLC’s holdings in West Pharmaceutical Services were worth $711,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Acrospire Investment Management LLC purchased a new position in shares of West Pharmaceutical Services during the 2nd quarter worth about $113,000. Citigroup Inc. lifted its holdings in shares of West Pharmaceutical Services by 95.1% during the 2nd quarter. Citigroup Inc. now owns 1,569 shares of the medical instruments supplier’s stock worth $148,000 after acquiring an additional 765 shares during the period. Harfst & Associates Inc. purchased a new position in shares of West Pharmaceutical Services during the 1st quarter worth about $186,000. Cambridge Investment Research Advisors Inc. lifted its holdings in shares of West Pharmaceutical Services by 1.6% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 2,569 shares of the medical instruments supplier’s stock worth $210,000 after acquiring an additional 40 shares during the period. Finally, Bradley Foster & Sargent Inc. CT purchased a new position in shares of West Pharmaceutical Services during the 2nd quarter worth about $212,000. Institutional investors and hedge funds own 90.57% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This report was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this report on another website, it was illegally copied and reposted in violation of United States & international copyright and trademark law. The legal version of this report can be read at https://www.thecerbatgem.com/2017/10/06/west-pharmaceutical-services-inc-wst-stake-lifted-by-virtu-kcg-holdings-llc.html.

WST has been the topic of several research reports. Jefferies Group LLC restated a “hold” rating and issued a $90.00 price target on shares of West Pharmaceutical Services in a report on Thursday, June 8th. BidaskClub lowered shares of West Pharmaceutical Services from a “hold” rating to a “sell” rating in a report on Thursday, July 27th. Zacks Investment Research lowered shares of West Pharmaceutical Services from a “hold” rating to a “sell” rating in a report on Wednesday, July 19th. Finally, Stephens initiated coverage on shares of West Pharmaceutical Services in a report on Tuesday. They issued an “equal weight” rating and a $99.00 price target on the stock. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $107.00.

West Pharmaceutical Services, Inc. (WST) opened at 94.84 on Friday. West Pharmaceutical Services, Inc. has a 12-month low of $70.17 and a 12-month high of $99.91. The company has a 50-day moving average of $90.88 and a 200 day moving average of $90.62. The stock has a market cap of $7.02 billion, a price-to-earnings ratio of 40.70 and a beta of 1.12.

West Pharmaceutical Services (NYSE:WST) last announced its quarterly earnings results on Thursday, July 27th. The medical instruments supplier reported $0.66 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.65 by $0.01. The business had revenue of $397.60 million during the quarter, compared to analyst estimates of $406.00 million. West Pharmaceutical Services had a return on equity of 14.02% and a net margin of 11.42%. The firm’s revenue was up 2.5% on a year-over-year basis. During the same period in the previous year, the company earned $0.59 EPS. Equities analysts anticipate that West Pharmaceutical Services, Inc. will post $2.68 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, November 1st. Stockholders of record on Wednesday, October 18th will be issued a dividend of $0.14 per share. This represents a $0.56 annualized dividend and a dividend yield of 0.59%. This is a positive change from West Pharmaceutical Services’s previous quarterly dividend of $0.13. The ex-dividend date is Tuesday, October 17th. West Pharmaceutical Services’s payout ratio is currently 22.22%.

West Pharmaceutical Services Profile

West Pharmaceutical Services, Inc is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services.

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Stock Ratings for West Pharmaceutical Services Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services Inc. and related stocks with our FREE daily email newsletter.